| |
Company
Roster
|
|
Total
Insiders : |
38 |
|
|
|
Total
Direct Shares :
|
7,656,255 |
|
|
Total
Indirect Shares :
|
29,364,194 |
| |
%
Held by Insiders:
|
12.31% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Melemed Allen S. |
|
2025-04-21 |
0 |
2023-01-17 |
0 |
| Sherman Michael A. |
|
2025-04-21 |
0 |
2025-04-21 |
0 |
| Andriole Michael T. |
|
2025-04-21 |
0 |
2019-11-06 |
0 |
| Middleton Fred A |
|
2025-04-21 |
0 |
2025-04-21 |
0 |
| Riga Thomas J |
|
2025-04-21 |
0 |
2025-01-07 |
0 |
| Alrutz Michael A |
|
2025-04-21 |
0 |
2019-02-05 |
0 |
| Meyer Robert J. |
|
2025-04-21 |
0 |
|
0 |
| Laspaluto Michelle |
|
2025-04-21 |
0 |
|
0 |
| Jakeman David |
|
2025-04-21 |
0 |
|
0 |
| Cantex Pharmaceuticals, Inc. |
10% Owner |
2021-09-14 |
3,500,000 |
|
0 |
| Demski Martha J |
|
2020-11-17 |
0 |
2025-04-21 |
0 |
| Nichols Garrett |
Chief Medical Officer |
2020-02-10 |
260,066 |
2016-05-09 |
0 |
| Trost Timothy W. |
SVP, CFO & Secretary |
2019-05-22 |
217,088 |
2013-10-25 |
0 |
| Berrey M Michelle |
President and CEO, Director |
2018-06-12 |
325,256 |
2018-06-12 |
99,685 |
| Mario Ernest |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
| Richardson Linda M |
Chief Commercial Officer |
2018-05-14 |
54,161 |
2016-05-09 |
0 |
| Wollaeger Timothy |
Director |
2016-03-01 |
10,000 |
2016-03-01 |
3,311,400 |
| Machado Clarence Patrick |
Director |
2015-12-29 |
10,000 |
2015-12-29 |
0 |
| Leonard John M. |
Director |
2015-08-21 |
4,000 |
2016-09-15 |
0 |
| Ricciardi Lisa |
Director |
2015-05-12 |
1,950 |
2015-05-12 |
0 |
| Rogers Michael D. |
Chief Development Officer |
2015-03-23 |
21,630 |
2014-04-25 |
0 |
| Sanderling Venture Partners V, Lp |
10% Owner |
2014-09-09 |
993,646 |
2014-09-12 |
3,311,400 |
| Sanderling Venture Partners Vi Co Investment Fund |
10% Owner |
2014-09-08 |
697,346 |
2014-09-05 |
0 |
| Canaan Partners Vii Llc |
Director |
2014-03-26 |
0 |
2013-10-23 |
2,584,990 |
| Ratcliffe Liam |
10% Owner |
2014-03-18 |
1,543,394 |
2014-03-18 |
0 |
| Moch Kenneth I |
President and CEO, Director |
2014-03-13 |
1,313 |
2013-11-15 |
0 |
| Drake Rodman L |
Director |
2013-12-09 |
3,500 |
2013-11-15 |
0 |
| Alta Embarcadero Biopharma Partners III Llc |
Stockholder |
2013-04-16 |
0 |
2013-04-16 |
2,161,829 |
| New Leaf Ventures Ii, L.p. |
10% Owner |
2013-04-16 |
0 |
2013-10-23 |
2,243,394 |
| Pv Iii Ceo Fund, L.p. |
Stockholder |
2013-04-16 |
0 |
2013-04-16 |
1,047,535 |
| Hutton Wende S |
Director, 10% Owner |
2013-04-16 |
0 |
2013-10-23 |
2,597,387 |
| Champsi Farah |
Director |
2013-04-16 |
0 |
2013-10-23 |
1,714,330 |
| Pappas Arthur M |
Director |
2013-04-16 |
0 |
2013-10-23 |
830,695 |
| Niedel James |
Director |
2013-04-16 |
0 |
2014-09-11 |
1,046,082 |
| Greissing Ed |
|
|
0 |
|
0 |
| Gilliss Catherine |
|
|
0 |
|
0 |
| Sanderling Ventures Management Vi |
10% Owner |
|
0 |
2013-11-13 |
4,153,650 |
| Sanderling Vi Beteiligungs Gmbh & Co Kg |
10% Owner |
|
0 |
2013-11-13 |
4,153,650 |
|
